Garth Kroeker

I strongly recommend a new book by Cambridge psychologist Sander van der Linden, entitled Foolproof: why misinformation infects our minds an...

The nutritional supplement industry has a global market size of over 300 billion US Dollars annually.   This is comparable to all the money ...

I encourage having a look at the September 2016 issue of The Canadian Journal of Psychiatry, which summarizes treatment recommendations for ...

Jacka et al. have just published in BMC Medicine (January 30, 2017) the results of a study showing that healthy dietary change leads to sign...

In my last post, I was discussing a technique of practicing exposure to recordings of upsetting thoughts. This same idea can be applied to...

I originally published this post in March, 2009.  I was just looking at it again today, while browsing through my blog...I thought I would r...

It is common practice in psychiatry to increase the dose of an antidepressant if the standard dose is not helping enough.  Sometimes doses a...

I read a recent review last week which warned against the use of quetiapine for treating non-psychotic mood disorders. Yet, I believe ther...

Duloxetine (Cymbalta) is another newer antidepressant, approved in the US in 2004, and in Canada in 2007.  It is a reuptake inhibitor of bot...

Vortioxetine is one of the newest antidepressants on the market, released in the U.S. in 2013.  It has serotonin and norepinephrine reuptake...

Desvenlafaxine (Pristiq) is an antidepressant that has been available since 2008-2009.  It is another example, similar to escitalopram, of a...

It is interesting how professional opinion can be swayed by trends in practice.   Escitalopram (Cipralex, or Lexapro) is a newer antidepres...

I have just updated and edited this article over the past few days. Ketamine is a drug which has been used in general anesthesia for decad...